Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06116526 · ClinicalTrials.gov registry record · Phase 4

Dupilumab De-escalation in Pediatric Atopic Dermatitis

A Phase 4 study of Atopic Dermatitis, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 4
Development phase
30
Enrollment target
1
Study location

NCT06116526 is a Phase 4 study of Atopic Dermatitis that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06116526, a Phase 4 study of Atopic Dermatitis, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 4
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a pilot investigator-blinded, randomized clinical trial to assess the feasibility of dupilumab treatment discontinuation or dose-reduction in children aged 1-17 years who have achieved sustained atopic dermatitis (AD) control on dupilumab.

Conditions Studied

Atopic Dermatitis

Interventions

  • DRUG Dupilumab - Standard Dose
  • DRUG Dupilumab - Discontinuation
  • DRUG Dupilumab - Dose Reduction

Study Locations (1)

Maryland

  • Johns Hopkins Univerisity - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-01
Est. Completion 2027-04-30
Phase Phase 4

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06116526

The ClinicalTrials.gov registry entry for NCT06116526 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (95% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 3 interventions - of which Dupilumab - Standard Dose is the first listed.

NCT06116526 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06116526 about?

NCT06116526 is a clinical study titled "Dupilumab De-escalation in Pediatric Atopic Dermatitis". This is a pilot investigator-blinded, randomized clinical trial to assess the feasibility of dupilumab treatment discontinuation or dose-reduction in children aged 1-17 years who have achieved sustained atopic dermatitis (AD) control on dupilumab.

What is the current status of trial NCT06116526?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2024-04-01. Estimated completion is 2027-04-30.

What conditions does trial NCT06116526 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT06116526?

The interventions under investigation include: Dupilumab - Standard Dose (DRUG), Dupilumab - Discontinuation (DRUG), Dupilumab - Dose Reduction (DRUG).

Who is sponsoring clinical trial NCT06116526?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06116526 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atopic Dermatitis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.